telomerase: 540-548 peptide vaccine

BIOLOGICAL3 trials

Sponsors

National Cancer Institute (NCI), Dana-Farber Cancer Institute, Abramson Cancer Center at Penn Medicine

Conditions

Brain and Central Nervous System TumorsBreast CancerGastrointestinal Stromal TumorMelanoma (Skin)SarcomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

CompletedNCT00069940

Dana-Farber Cancer InstituteBrain and Central Nervous System Tumors, Gastrointestinal Stromal Tumor, Sarcoma

Start: 2000-12-31End: 2008-08-31Updated: 2010-12-28

Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer

CompletedNCT00079157

Abramson Cancer Center at Penn MedicineBreast Cancer

Start: 2004-02-29End: 2007-12-31Target: 28Updated: 2020-02-05

Phase 2

Vaccine Therapy in Treating Patients With Metastatic Cancer

CompletedNCT00021164

National Cancer Institute (NCI)Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific

Start: 2001-05-31End: 2004-05-31Updated: 2013-06-19